Table 2 Correlations between Gleason score (grades group) and clinical stage
T1cN0M0 | T2a-bN0M0 | T2cN0M0 | T3N0M0 | TxN1M0 | TxNxM1 | |
|---|---|---|---|---|---|---|
GS 6 (GG 1) | 17 (54.8%) | 7 (22.6%) | 7 (22.6%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
GS 3 + 4 (GG 2) | 16 (55.2%) | 8 (27.6%) | 5 (17.2%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
GS 4 + 3 (GG 3) | 3 (42.9%) | 4 (57.1%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
GS 8 (GG 4) | 2 (22.2%) | 5 (55.6%) | 0 (0.0%) | 1 (11.1%) | 0 (0.0%) | 1 (11.1%) |
GS 9–10 (GG5) | 3 (33.3%) | 3 (33.3%) | 1 (11.1%) | 2 (22.2%) | 0 (0.0%) | 0 (0.0%) |